Report: Global biosimilars market could reach $2.5B this year

05/7/2013 | Drug Store News

The global biosimilars market is forecast to expand to $2.5 billion this year, a growth of more than 20% from 2012, according to a report from U.K.-based firm Visiongain. The market could see rapid expansion through 2023 as biosimilar drugs enter the U.S. and European markets. Biosimilar versions of monoclonal antibodies and insulins will record the fastest growth, according to the report, which point to the potential product launches in Europe and the U.S. next year.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD